Neuro Innovators conducts rigorous research to develop new treatments that help stroke survivors regain independence. By repurposing FDA‑approved drugs, they aim to shorten development timelines and lower risk while testing these approaches in a Phase 1 clinical trial at Spaulding Rehabilitation Hospital. Their work combines compassionate care with scientific collaboration to accelerate access to effective brain‑recovery therapies.
Funding
Funding not disclosed
Founders
Product
Problem
Stroke survivors often experience lasting neurological deficits that limit their independence and quality of life, yet existing therapeutic options for post‑stroke brain recovery are limited and development of new drugs is lengthy and costly.
Solution
Neuro Innovators conducts focused research to identify new applications for existing FDA‑approved medications, aiming to accelerate the availability of effective treatments for brain recovery after stroke. By repurposing drugs with known safety profiles, the company reduces the time and financial risk associated with traditional drug development. Its current Phase 1 clinical trial, conducted in partnership with Spaulding Rehabilitation Hospital, evaluates the safety and preliminary efficacy of these repurposed agents in stroke patients. The trial design emphasizes compassionate care and functional outcomes that directly support patients’ return to independence. Findings from the study will inform larger trials and potential regulatory pathways for rapid translation into clinical practice.
Target Audience
Primary customers are rehabilitation hospitals, neurologists, and clinical research organizations seeking evidence‑based pharmacologic options to enhance post‑stroke recovery.
Features
- Systematic screening of FDA‑approved compounds for mechanisms that promote neuroplasticity and functional recovery after stroke
- Leveraging existing safety and pharmacokinetic data to shorten preclinical and early clinical development timelines
- Collaboration with Spaulding Rehabilitation Hospital, a nationally ranked rehabilitation center, to conduct a Phase 1 trial in a real‑world clinical setting
- Clinical trial protocol focused on functional independence metrics and patient‑centered outcomes
- Integrated data platform for rapid analysis of safety, biomarker, and efficacy signals to guide go‑no‑go decisions